Artificial pancreas | OCD therapies | Fructose and fatty liver disease

September 15, 2020 Edition  COVID-19 is an emerging, rapidly evolving situation, and we at NIH are doing everything we can toward the development of diagnostics, therapeutics, and vaccines. You can find the latest public health information from CDC at www.coronavirus.gov and the latest research information from NIH at www.nih.gov/coronavirus. Meanwhile, science continues to progress on many other fronts, and we will continue to try to bring you stories across a wide range of topics.

Artificial pancreas helps children with type 1 diabetes A new artificial pancreas system, which monitors and regulates blood glucose levels, proved safe and effective in young children with type 1 diabetes.

Brain scans may help predict response to OCD therapies Differences in brain activity seen on scans taken before psychotherapy for obsessive-compulsive disorder corresponded with responses to treatment.

How high fructose intake may trigger fatty liver disease A study suggested that consuming high amounts of fructose may promote non-alcoholic fatty liver disease by damaging the intestinal barrier.

Popular Stories: Experimental coronavirus vaccine is safe and produces immune response Potent antibodies found in people recovered from COVID-19 Study suggests new coronavirus may remain on surfaces for days Immune cells for common cold may recognize SARS-CoV-2 Novel coronavirus structure reveals targets for vaccines and treatments